Catapro Pharmalab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 9 Months
About Catapro Pharmalab
Catapro Pharmalab Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 2023 (One year and nine months 9 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Wood Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shrikant Karwa, Shweta Karwa, Manju Karwa, and One other member serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U20119MH2023PTC403283
- Company No.
403283
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Catapro Pharmalab?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shrikant Karwa  | Director | 19-May-2023 | Current |
| Shweta Karwa | Director | 17-Aug-2023 | Current |
| Manju Karwa | Director | 19-May-2023 | Current |
| Shruti Karwa | Director | 19-May-2023 | Current |
Financial Performance of Catapro Pharmalab.
Enhance accessibility to Catapro Pharmalab's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Catapro Pharmalab?
Unlock access to Catapro Pharmalab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Catapharma Chemicals Private LimitedShrikant Karwa and Shruti Karwa are mutual person
- Mdb Chemicals (India) Private Limited
Shrikant Karwa is a mutual person
- Catapharma (India) Pvt Ltd
Shrikant Karwa and Manju Karwa are mutual person
Recat Digital Solutions Private LimitedShrikant Karwa is a mutual person
- Dr. Shrikant Karwa Foundation
Shrikant Karwa and Manju Karwa are mutual person
- Sinnar Enviro Foundation
Shrikant Karwa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Catapro Pharmalab?
Unlock and access historical data on people associated with Catapro Pharmalab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catapro Pharmalab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catapro Pharmalab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.